Evidence map›Paper›PMID 29674727›Full record

ArticleScientific reports2018

Acute Hyperthermia Inhibits TGF-β1-induced Cardiac Fibroblast Activation via Suppression of Akt Signaling.

Masatoshi Narikawa, Masanari Umemura, Ryo Tanaka, Takayuki Fujita, Utako Yokoyama, Tomoaki Ishigami, Kazuo Kimura, Kouichi Tamura, Yoshihiro Ishikawa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. 7-nm MnTheranostics · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Prostaglandin ECancer science · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Masatoshi NarikawaCardiovascular Research Institute, Yokohama City University School of Medicine, Yokohama, Japan.ORCID 0000-0003-1017-4234
Masanari UmemuraCardiovascular Research Institute, Yokohama City University School of Medicine, Yokohama, Japan. umemurma@yokohama-cu.ac.jp.ORCID 0000-0002-1812-5720
Ryo TanakaCardiovascular Research Institute, Yokohama City University School of Medicine, Yokohama, Japan.
Takayuki FujitaCardiovascular Research Institute, Yokohama City University School of Medicine, Yokohama, Japan.
Utako YokoyamaCardiovascular Research Institute, Yokohama City University School of Medicine, Yokohama, Japan.
Tomoaki IshigamiMedical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Yokohama, Japan.
Kazuo KimuraMedical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Yokohama, Japan.
Kouichi TamuraMedical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, Yokohama, Japan.
Yoshihiro IshikawaCardiovascular Research Institute, Yokohama City University School of Medicine, Yokohama, Japan. yishikaw@med.yokohama-cu.ac.jp.
Cardiovascular Institute Hospital · JPYokohama City University · JPYokohama City University Medical Center · JPYokohama University of Pharmacy · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor-β1 (TGF-β1) induces phenotypic changes in fibroblasts to become myofibroblasts with increased production of extracellular matrix (ECM) components and cytokines. It is also known that excessive activation of myofibroblasts accelerates cardiac fibrosis, remodeling, and thus cardiac dysfunction. However, no effective therapy has been established to prevent this process although recent clinical studies have demonstrated the effectiveness of hyperthermia in cardiac dysfunction. The aim of this study was to examine the molecular mechanism of hyperthermia on TGF-β1-mediated phenotypic changes in cardiac fibroblasts. TGF-β1 increased the expression of IL-6, α-smooth muscle actin (α-SMA), and collagen in human cardiac fibroblasts (HCFs). Hyperthermia (42 °C) significantly prevented these changes, i.e., increases in IL-6, α-SMA, and collagen, as induced by TGF-β1 in a time-dependent manner. Immunoblotting showed that hyperthermia decreased Akt/S6K signaling, but did not affect Smad2 and Smad3 signaling. Pharmacological inhibition of Akt signaling mimicked these effects of hyperthermia. Furthermore, hyperthermia treatment prevented cardiac fibrosis in Ang II infusion mice model. Putting together, our findings suggest that hyperthermia directly inhibits TGF-β-mediated activation of HCFs via suppressing Akt/S6K signaling.

Indexed as

Signal TransductionActinsAcute DiseaseAngiotensin IIAnimalsDisease Models, AnimalFeverFibroblastsHumansInterleukin-6MaleMiceMice, Inbred C57BLMyocardiumProto-Oncogene Proteins c-aktRNA, MessengerACTA2 protein, humanActinsAngiotensin IIIL6 protein, humanInterleukin-6Proto-Oncogene Proteins c-aktRNA, MessengerTransforming Growth Factor beta1

Identifiers

PMID29674727
PMCPMC5908876
OpenAlexW2806131394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.